NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Christopher M. Smith$1.8B
Market Cap • 23/04/20241998
(há 26 anos)
1996
(28 years ago)
NASDAQ
Listagem
Fort Myers
Sede • Florida2.100
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
NEOSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.